이 페이지의 번역은 실험적이며 개발 중입니다. 여러분의 환영합니다!

KBG 관리

관리 기준 확인 0/4

현재 CEO에 대한 정보가 충분하지 않습니다.

주요 정보

Samuel Boo

최고 경영자

n/a

총 보상

CEO 급여 비율	n/a
CEO 임기	1.3yrs
CEO 소유권	n/a
경영진 평균 재임 기간	데이터 없음
이사회 평균 재임 기간	데이터 없음

최근 관리 업데이트

Recent updates

We Think That There Are Some Issues For KBG (KOSDAQ:318000) Beyond Its Promising Earnings

May 21

If You Had Bought Korea Bio-GenLtd (KOSDAQ:318000) Stock A Year Ago, You Could Pocket A 33% Gain Today

Mar 02

CEO

Samuel Boo (38 yo)

1.3yrs

테뉴어

Samuel Boo is Director of KBG Corp. and is its CEO since March 23, 2023.

KBG 관리

관리 기준 확인 0/4

주요 정보

최근 관리 업데이트

Korea Bio-Gen Co.,Ltd, Annual General Meeting, Mar 26, 2021

Recent updates

We Think That There Are Some Issues For KBG (KOSDAQ:318000) Beyond Its Promising Earnings

Inaugural dividend of ₩99.50 per share

New major risk - Share price stability

Investor sentiment improves as stock rises 21%

Investor sentiment improves as stock rises 28%

Investor sentiment deteriorates as stock falls 18%

New minor risk - Shareholder dilution

Investor sentiment deteriorates as stock falls 15%

Investor sentiment improves as stock rises 19%

Investor sentiment improves as stock rises 57%

Investor sentiment improves as stock rises 21%

Investor sentiment improves as stock rises 42%

Inaugural dividend of ₩100.00 per share

Third quarter 2022 earnings released: EPS: ₩169 (vs ₩117 in 3Q 2021)

Investor sentiment improved over the past week

Investor sentiment deteriorated over the past week

Investor sentiment deteriorated over the past week

Inaugural dividend of ₩75.00 per share

Third quarter 2021 earnings released: EPS ₩117 (vs ₩121 in 3Q 2020)

Investor sentiment improved over the past week

Korea Bio-Gen Co.,Ltd announced that it has received KRW 5 billion in funding from Daegyeong Investment Co., Ltd. and another investor

Korea Bio-Gen Co.,Ltd announced that it expects to receive KRW 5 billion in funding from Daegyeong Investment Co., Ltd. and another investor

If You Had Bought Korea Bio-GenLtd (KOSDAQ:318000) Stock A Year Ago, You Could Pocket A 33% Gain Today

Korea Bio-Gen Co.,Ltd, Annual General Meeting, Mar 26, 2021

The Trends At Korea Bio-GenLtd (KOSDAQ:318000) That You Should Know About

Investor sentiment improved over the past week

New 90-day high: ₩10,950

New 90-day high: ₩8,390

Should You Be Impressed By Korea Bio-Gen Co.,Ltd's (KOSDAQ:318000) ROE?

First Dividend Is ₩50.00 Per Share

Calculating The Intrinsic Value Of Korea Bio-Gen Co.,Ltd (KOSDAQ:318000)

New 90-day low: ₩6,880

New 90-day high - ₩7,500

CEO

테뉴어